Is Enanta Pharmaceuticals, Inc. (ENTA) a Buy, Sell, or Hold?
NASDAQ : ENTA
Enanta Pharmaceuticals, Inc. — Competitors
$13.77 USD
$0.43 (3.22%)
- Volume
- 182.99K
- Average Volume
- 171.4K
- Market Capitalization
- $400.41M
- P/E Ratio
- -5.03
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $17.15
- Year Low
- $6.45
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.84
ENTA vs. The Competition
| Properties | ENTA | ASMB | AVIR | CRBU |
|---|---|---|---|---|
| Market Cap | $400.41M | $424.02M | $420.14M | $163.65M |
| Shares Outstanding | $29.08M | $15.89M | $80.03M | $99.18M |
| P/E Ratio | -5.03 | -46.0 | -2.49 | -1.16 |
| EPS | -2.9 | -0.38 | -2.14 | -1.39 |
| Day Low | 13.35 | 26.36 | 4.97 | 1.625 |
| Day High | 13.87 | 27.12 | 5.27 | 1.67 |
| Year Low | 6.45 | 20.23 | 2.78 | 1.38 |
| Year High | 17.15 | 39.71 | 6.45 | 3.535 |
| Average Price 50 | 13.0546 | 25.733 | 4.6266 | 1.7569 |
| Average Price 200 | 13.3605 | 29.1673 | 4.395 | 1.8584 |
| Volume | 182.99K | 119.77K | 264.99K | 806.04K |
| Average Volume | - | - | - | - |